$HAE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in HAEMONETICS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in HAEMONETICS CORP. Get notifications about new insider transactions in HAEMONETICS CORP for free.
Page: < prev 1 ... 5 6 7 8 9 10 11 12 13 ... 16 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 30 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 78.51 | 1,284 | 100,807 | 60,140 | 61.4 K to 60.1 K (-2.09 %) |
Oct 30 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | D | 78.51 | 180 | 14,132 | 13,357 | 13.5 K to 13.4 K (-1.33 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Option Exercise | A | 78.11 | 16,096 | 1,257,259 | 16,096 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | White Jonathan | VP Research and Dev ... | Grant | A | 0.00 | 1,728 | 0 | 12,834 | 11.1 K to 12.8 K (+15.56 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | Nighan Warren JR | VP WW Q&R Affairs | Option Exercise | A | 78.11 | 14,307 | 1,117,520 | 14,307 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | Nighan Warren JR | VP WW Q&R Affairs | Grant | A | 0.00 | 1,536 | 0 | 4,382 | 2.8 K to 4.4 K (+53.97 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Option Exercise | A | 78.11 | 19,672 | 1,536,580 | 19,672 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Grant | A | 0.00 | 2,112 | 0 | 6,035 | 3.9 K to 6 K (+53.84 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Option Exercise | A | 78.11 | 23,249 | 1,815,979 | 23,249 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Grant | A | 0.00 | 2,496 | 0 | 15,803 | 13.3 K to 15.8 K (+18.76 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | Jesse Sandra | VP & CLO | Option Exercise | A | 78.11 | 14,307 | 1,117,520 | 14,307 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | Jesse Sandra | VP & CLO | Grant | A | 0.00 | 1,536 | 0 | 3,748 | 2.2 K to 3.7 K (+69.44 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | Helsel Dave | VP, Global Manufact ... | Option Exercise | A | 78.11 | 14,307 | 1,117,520 | 14,307 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | Helsel Dave | VP, Global Manufact ... | Grant | A | 0.00 | 1,536 | 0 | 3,312 | 1.8 K to 3.3 K (+86.49 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | A | 78.11 | 8,441 | 659,327 | 8,441 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Grant | A | 0.00 | 906 | 0 | 8,278 | 7.4 K to 8.3 K (+12.29 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | A | 78.11 | 3,576 | 279,321 | 3,576 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Grant | A | 0.00 | 384 | 0 | 8,802 | 8.4 K to 8.8 K (+4.56 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | A | 78.11 | 125,191 | 9,778,669 | 125,191 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Grant | A | 0.00 | 13,442 | 0 | 61,424 | 48 K to 61.4 K (+28.01 %) |
Oct 26 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | A | 78.11 | 16,096 | 1,257,259 | 16,096 | |
Oct 26 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Grant | A | 0.00 | 1,728 | 0 | 13,537 | 11.8 K to 13.5 K (+14.63 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Sell | D | 77.82 | 322 | 25,058 | 13,307 | 13.6 K to 13.3 K (-2.36 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Sell | D | 78.04 | 142 | 11,082 | 13,629 | 13.8 K to 13.6 K (-1.03 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | D | 78.04 | 73 | 5,697 | 7,372 | 7.4 K to 7.4 K (-0.98 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | D | 78.04 | 79 | 6,165 | 8,418 | 8.5 K to 8.4 K (-0.93 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | D | 78.04 | 189 | 14,749 | 47,982 | 48.2 K to 48 K (-0.39 %) |
Oct 25 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | D | 78.04 | 101 | 7,882 | 11,809 | 11.9 K to 11.8 K (-0.85 %) |
Oct 10 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | M | 21.46 | 10,000 | 214,600 | 21,414 | |
Oct 10 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | S | 81.09 | 10,000 | 810,933 | 11,910 | 21.9 K to 11.9 K (-45.64 %) |
Oct 10 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Buy | M | 21.46 | 10,000 | 214,600 | 21,910 | 11.9 K to 21.9 K (+83.96 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 7,644 | |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 55,000 | |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 80.73 | 5,000 | 403,631 | 48,171 | 53.2 K to 48.2 K (-9.40 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 53,171 | 48.2 K to 53.2 K (+10.38 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 80.73 | 1,500 | 121,089 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Oct 03 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Sep 12 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 52.76 | 4,931 | 260,160 | 0 | |
Sep 12 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | M | 52.76 | 1,069 | 56,400 | 4,931 | |
Sep 12 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 75.80 | 4,931 | 373,776 | 5,176 | 10.1 K to 5.2 K (-48.79 %) |
Sep 12 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 52.76 | 4,931 | 260,160 | 10,107 | 5.2 K to 10.1 K (+95.27 %) |
Sep 12 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Sell | S | 76.00 | 1,069 | 81,244 | 5,176 | 6.2 K to 5.2 K (-17.12 %) |
Sep 12 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Buy | M | 52.76 | 1,069 | 56,400 | 6,245 | 5.2 K to 6.2 K (+20.65 %) |
Sep 17 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | M | 52.76 | 5,373 | 283,479 | 0 | |
Sep 17 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 80.00 | 5,373 | 429,840 | 8,497 | 13.9 K to 8.5 K (-38.74 %) |
Sep 17 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | M | 52.76 | 5,373 | 283,479 | 13,870 | 8.5 K to 13.9 K (+63.23 %) |
Sep 12 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | M | 21.46 | 2,100 | 45,066 | 31,414 | |
Sep 12 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | S | 75.64 | 2,100 | 158,850 | 11,910 | 14 K to 11.9 K (-14.99 %) |
Sep 12 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Buy | M | 21.46 | 2,100 | 45,066 | 14,010 | 11.9 K to 14 K (+17.63 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Option Exercise | M | 51.07 | 21,238 | 1,084,625 | 0 | |
Sep 06 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Option Exercise | M | 48.09 | 40,545 | 1,949,809 | 0 | |
Sep 06 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Sell | S | 75.00 | 21,238 | 1,592,850 | 13,771 | 35 K to 13.8 K (-60.66 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Buy | M | 51.07 | 21,238 | 1,084,625 | 35,009 | 13.8 K to 35 K (+154.22 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Sell | S | 74.00 | 40,545 | 3,000,330 | 13,771 | 54.3 K to 13.8 K (-74.65 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | CFO & Vice Presiden ... | Buy | M | 48.09 | 40,545 | 1,949,809 | 54,316 | 13.8 K to 54.3 K (+294.42 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 9,144 | |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 60,000 | |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 73.67 | 5,000 | 368,374 | 48,171 | 53.2 K to 48.2 K (-9.40 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 53,171 | 48.2 K to 53.2 K (+10.38 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 73.70 | 1,500 | 110,550 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Sep 06 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Aug 27 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | M | 44.74 | 6,000 | 268,440 | 0 | |
Aug 27 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 71.90 | 6,000 | 431,400 | 12,417 | 18.4 K to 12.4 K (-32.58 %) |
Aug 27 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Buy | M | 44.74 | 6,000 | 268,440 | 18,417 | 12.4 K to 18.4 K (+48.32 %) |
Aug 15 2012 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | M | 44.74 | 6,000 | 268,440 | 0 | |
Aug 15 2012 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Sell | S | 70.05 | 6,000 | 420,310 | 6,626 | 12.6 K to 6.6 K (-47.52 %) |
Aug 15 2012 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Buy | M | 44.74 | 6,000 | 268,440 | 12,626 | 6.6 K to 12.6 K (+90.55 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 10,644 | |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 5,000 | 113,175 | 65,000 | |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.68 | 5,000 | 358,425 | 48,171 | 53.2 K to 48.2 K (-9.40 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 5,000 | 113,175 | 53,171 | 48.2 K to 53.2 K (+10.38 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 71.92 | 1,500 | 107,876 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Aug 02 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Aug 01 2012 | HAE | HAEMONETICS CORP | Kelly Michael P | President, Global M ... | Sell | D | 72.73 | 175 | 12,728 | 3,923 | 4.1 K to 3.9 K (-4.27 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Option Exercise | A | 72.74 | 5,464 | 397,451 | 5,464 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | Zane Ellen M | Director | Grant | A | 0.01 | 1,374 | 14 | 1,374 | 0 to 1.4 K |
Jul 31 2012 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Grant | A | 0.01 | 1,031 | 10 | 6,176 | 5.1 K to 6.2 K (+20.04 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | MEELIA RICHARD J | Director | Grant | A | 0.01 | 1,031 | 10 | 4,250 | 3.2 K to 4.3 K (+32.03 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Grant | A | 0.01 | 1,031 | 10 | 4,176 | 3.1 K to 4.2 K (+32.78 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | GRANADILLO PEDRO P | Director | Grant | A | 0.01 | 1,031 | 10 | 6,626 | 5.6 K to 6.6 K (+18.43 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Grant | A | 0.01 | 1,031 | 10 | 12,417 | 11.4 K to 12.4 K (+9.05 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | FOOTE SUSAN BARTLETT | Director | Grant | A | 0.01 | 1,031 | 10 | 5,176 | 4.1 K to 5.2 K (+24.87 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | Black Paul | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | Black Paul | Director | Grant | A | 0.01 | 1,031 | 10 | 3,666 | 2.6 K to 3.7 K (+39.13 %) |
Jul 31 2012 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Option Exercise | A | 72.74 | 4,098 | 298,089 | 4,098 | |
Jul 31 2012 | HAE | HAEMONETICS CORP | BEST LAWRENCE C | Director | Grant | A | 0.01 | 1,031 | 10 | 4,176 | 3.1 K to 4.2 K (+32.78 %) |
Jul 11 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 52.76 | 7,282 | 384,198 | 0 | |
Jul 11 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 73.98 | 7,282 | 538,751 | 7,445 | 14.7 K to 7.4 K (-49.45 %) |
Jul 11 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 52.76 | 7,282 | 384,198 | 14,727 | 7.4 K to 14.7 K (+97.81 %) |
Jul 11 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Option Exercise | M | 21.46 | 10,000 | 214,600 | 33,514 | |
Jul 11 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Sell | S | 73.98 | 10,000 | 739,800 | 11,910 | 21.9 K to 11.9 K (-45.64 %) |
Jul 11 2012 | HAE | HAEMONETICS CORP | ALLEN PETER M | President, Global P ... | Buy | M | 21.46 | 10,000 | 214,600 | 21,910 | 11.9 K to 21.9 K (+83.96 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 12,144 | |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 70,000 | |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 74.02 | 3,000 | 222,048 | 48,171 | 51.2 K to 48.2 K (-5.86 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,171 | 48.2 K to 51.2 K (+6.23 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 74.01 | 1,500 | 111,015 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Jul 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Jul 03 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | M | 52.76 | 5,000 | 263,800 | 5,373 | |
Jul 03 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 74.00 | 5,000 | 370,000 | 8,497 | 13.5 K to 8.5 K (-37.05 %) |
Jul 03 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | M | 52.76 | 5,000 | 263,800 | 13,497 | 8.5 K to 13.5 K (+58.84 %) |
Jun 25 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | M | 48.20 | 12,000 | 578,340 | 0 | |
Jun 25 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 71.14 | 12,000 | 853,656 | 8,497 | 20.5 K to 8.5 K (-58.55 %) |
Jun 25 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | M | 48.20 | 12,000 | 578,340 | 20,497 | 8.5 K to 20.5 K (+141.23 %) |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | M | 48.20 | 11,000 | 530,145 | 12,000 | |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | M | 48.20 | 13,000 | 626,535 | 23,000 | |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 72.40 | 11,000 | 796,375 | 8,497 | 19.5 K to 8.5 K (-56.42 %) |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | M | 48.20 | 11,000 | 530,145 | 19,497 | 8.5 K to 19.5 K (+129.46 %) |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 72.23 | 13,000 | 939,030 | 8,497 | 21.5 K to 8.5 K (-60.47 %) |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | M | 48.20 | 13,000 | 626,535 | 21,497 | 8.5 K to 21.5 K (+153.00 %) |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Option Exercise | M | 48.20 | 14,000 | 674,730 | 36,000 | |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Sell | S | 72.35 | 14,000 | 1,012,939 | 8,497 | 22.5 K to 8.5 K (-62.23 %) |
Jun 21 2012 | HAE | HAEMONETICS CORP | FORISH JOSEPH J | VP, Human Resources | Buy | M | 48.20 | 14,000 | 674,730 | 22,497 | 8.5 K to 22.5 K (+164.76 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 52.76 | 1,500 | 79,140 | 13,644 | |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Option Exercise | M | 22.64 | 3,000 | 67,905 | 73,000 | |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 68.47 | 3,000 | 205,412 | 48,171 | 51.2 K to 48.2 K (-5.86 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 22.64 | 3,000 | 67,905 | 51,171 | 48.2 K to 51.2 K (+6.23 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Sell | S | 68.59 | 1,500 | 102,882 | 48,171 | 49.7 K to 48.2 K (-3.02 %) |
Jun 05 2012 | HAE | HAEMONETICS CORP | CONCANNON BRIAN | President & CEO | Buy | M | 52.76 | 1,500 | 79,140 | 49,671 | 48.2 K to 49.7 K (+3.11 %) |
Jun 01 2012 | HAE | HAEMONETICS CORP | Kelly Michael P | President | Sell | D | 69.88 | 163 | 11,391 | 4,098 | 4.3 K to 4.1 K (-3.83 %) |
May 21 2012 | HAE | HAEMONETICS CORP | GELBMAN RONALD G | Director | Sell | S | 71.49 | 2,473 | 176,795 | 11,386 | 13.9 K to 11.4 K (-17.84 %) |
May 09 2012 | HAE | HAEMONETICS CORP | MERRIMAN RONALD | Director | Sell | S | 71.46 | 1,000 | 71,456 | 5,145 | 6.1 K to 5.1 K (-16.27 %) |
May 08 2012 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Option Exercise | M | 48.77 | 20,000 | 975,300 | 0 | |
May 08 2012 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Sell | S | 71.09 | 20,000 | 1,421,762 | 3,145 | 23.1 K to 3.1 K (-86.41 %) |
May 08 2012 | HAE | HAEMONETICS CORP | KROLL MARK W | Director | Buy | M | 48.77 | 20,000 | 975,300 | 23,145 | 3.1 K to 23.1 K (+635.93 %) |
May 08 2012 | HAE | HAEMONETICS CORP | Nighan Warren JR | VP WW Q&R Affairs | Option Exercise | M | 59.43 | 3,128 | 185,897 | 9,386 | |
May 08 2012 | HAE | HAEMONETICS CORP | Nighan Warren JR | VP WW Q&R Affairs | Sell | S | 70.98 | 379 | 26,900 | 2,846 | 3.2 K to 2.8 K (-11.75 %) |
May 08 2012 | HAE | HAEMONETICS CORP | Nighan Warren JR | VP WW Q&R Affairs | Sell | S | 70.97 | 3,128 | 222,001 | 3,225 | 6.4 K to 3.2 K (-49.24 %) |
May 08 2012 | HAE | HAEMONETICS CORP | Nighan Warren JR | VP WW Q&R Affairs | Buy | M | 59.43 | 3,128 | 185,897 | 6,353 | 3.2 K to 6.4 K (+96.99 %) |
May 07 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 41.15 | 5,000 | 205,750 | 0 | |
May 07 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Option Exercise | M | 30.39 | 3,000 | 91,155 | 0 | |
May 07 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 71.44 | 3,000 | 214,320 | 7,445 | 10.4 K to 7.4 K (-28.72 %) |
May 07 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 30.39 | 3,000 | 91,155 | 10,445 | 7.4 K to 10.4 K (+40.30 %) |
May 07 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Sell | S | 71.44 | 5,000 | 357,200 | 7,445 | 12.4 K to 7.4 K (-40.18 %) |
May 07 2012 | HAE | HAEMONETICS CORP | HANLON SUSAN M | VP Finance | Buy | M | 41.15 | 5,000 | 205,750 | 12,445 | 7.4 K to 12.4 K (+67.16 %) |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Option Exercise | M | 55.14 | 6,980 | 384,877 | 8,000 | |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Option Exercise | M | 54.99 | 4,735 | 260,378 | 14,205 | |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Option Exercise | M | 54.55 | 11,435 | 623,779 | 3,812 | |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Option Exercise | M | 52.94 | 9,793 | 518,441 | 9,794 | |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Sell | S | 71.87 | 6,980 | 501,673 | 4,442 | 11.4 K to 4.4 K (-61.11 %) |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Buy | M | 55.14 | 6,980 | 384,877 | 11,422 | 4.4 K to 11.4 K (+157.14 %) |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Sell | S | 71.87 | 11,435 | 821,867 | 4,442 | 15.9 K to 4.4 K (-72.02 %) |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Buy | M | 54.55 | 11,435 | 623,779 | 15,877 | 4.4 K to 15.9 K (+257.43 %) |
May 03 2012 | HAE | HAEMONETICS CORP | Gordon Mikael | President, Global M ... | Sell | S | 71.87 | 4,735 | 340,318 | 4,442 | 9.2 K to 4.4 K (-51.60 %) |